Hong Kong Journal of Nephrology
Volume 13, Issue 1 , Pages 5-18, April 2011

Renal Disease in Hematological Malignancies

  • Ibrahiem Saeed Abdul-Rahman

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Ibrahiem Saeed Abdul-Rahman, Department of Internal Medicine, King Fahd Hospital of the University, Dammam University, PO Box 40032, Al-Khobar 31952, Saudi Arabia

Department of Internal Medicine, Nephrology Subdivision, King Fahd Hospital of the University, Dammam University, Al-Khobar, Saudi Arabia

Article Outline

Hematological malignancies can affect the kidneys in different ways. There may be direct invasion by the tumor cells, or the malignancy may act indirectly via immunologically mediated mechanisms. Primary renal lymphoma (PRL) without evidence of extrarenal spread has also been reported. The existence of this entity, however, has been questioned, because the kidneys do not normally contain lymphoid tissue. Renal involvement is rare in leukemias, and in some leukemias, renal dysfunction is usually found during the blastic crisis. Renal infiltration of leukemic cells has been recognized in some patients. In addition, some types of hematological neoplasia are associated with severe hypercalcemia that can lead to nephrocalcinosis. Renal involvement is one of the major manifestations of multiple myeloma (MM) and is an important cause of renal failure in the elderly. Renal failure occurs in more than 50% of MM patients, and is usually caused by the so-called myeloma kidney. Tumor lysis syndrome (TLS) is an oncological emergency characterized by a combination of metabolic disorders observed at the start of treatment of hematological malignancies. TLS may also be associated with the advancement of aggressive lymphomas and leukemias. The syndrome is frequently associated with renal dysfunction. Bone marrow transplantation for treatment of selected hematological neoplasms can be complicated by renal failure resulting from a variety of causes. Early renal injury most often results from infection and its subsequent treatment. Late renal injury after bone marrow transplantation, characterized by a syndrome similar to the hemolytic uremic syndrome, is called bone marrow transplant (BMT) nephropathy. This article reviews the clinical and pathological features of renal injury in hematological malignancies.

Key words:  BMT , leukemia , lymphoma , multiple myeloma , tumor lysis

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Olusanya AA , Huff G , Adeleye O , et al.   Primary renal non-Hodgkin's lymphoma presenting with acute renal failure . J NatI Med Assoc . 2003;95:220–224
  2. Troung LD , Soroka S , Seth AV , et al.   Primary lymphoma presenting as acute renal failure . Am J Kidney Dis . 1987;9:502–506
  3. Mills NE , Goldenberg AS , Liu D , et al.   B-cell lymphoma presenting as infiltrative renal disease . Am J Kidney Dis . 1992;19:181–184
  4. Malbrain ML , Lambercht GL , Daelemans R , et al.   Acute renal failure due to bilateral lymphomatous infiltrates: primary extranodal non-Hodgkin's lymphoma (p-EN-NHL) of the kidneys: does it really exist? . Clin Nephrol . 1994;42:163–169
  5. Kandel LB , McCullough DL , Harrison LH , et al.   Primary renal lymphoma: does it exist? . Cancer . 1987;60:386–391
  6. Stallone G , Infante B , Manno C , et al.   Primary renal lymphoma does exist: case report and review of literature . J Nephrol . 2000;13:367–372
  7. Choi JH , Choi GB , Shim KN , et al.   Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy . Acta Haematol . 1997;97:231–235
  8. Yasunaga Y , Hoshida Y , Hashimoto M , et al.   Malignant lymphoma of the kidney . J Surg Oncol . 1997;64:207–211
  9. Rajappa S , Digumarti R , Immaneni SR , et al.   Primary renal lymphoma presenting with paraneoplastic limbic encephalitis . J Clin Oncol . 2007;25:3783–3785
  10. Markert A , May A , Weber J , et al.   Bilateral renal lymphoma after paraneoplastic limbic encephalitis . J Clin Oncol . 2009;27:1142–1144
  11. Berard RJ , Thompson C , Verani R , et al.   Lymphoma presenting as acute renal failure . Am J Med . 1988;84:366–367
  12. JP Brouland , F Meeus , J Rossert , et al.   Primary bilateral B-cell renal lymphoma: a case report and review of the literature . Am J Kidney Dis . 1994;24:586–589
  13. Ferry JA , Harris NL , Papanicolaou N , et al.   Lymphoma of the kidney: a report of 11 cases . Am J Surg Pathol . 1995;19:134–144
  14. Miyaki JS , Fitterer S , Houghton DC . Diagnosis and characterization of non-Hodgkin's lymphoma in a patient with acute renal failure . Am J Kidney Dis . 1990;16:262–263
  15. Poulis C . Primary renal non-Hodgkin's lymphoma . Scand J Urol Nephrol . 1990;24:227–230
  16. Dobkin SF , Brem AS , Caldmone AA . Primary renal lymphoma . J Urol . 1991;146:1588–1590
  17. Harris GJ , Lager DJ . Primary renal lymphoma . J Surg Oncol . 1991;46:263–277
  18. Vandermolen LA , Dillman RO . Primary lymphoma of the kidney: complete remission after systemic chemotherapy . J Natl Cancer Inst . 1993;85:505–506
  19. Bertoncelli C , Airoldi G , Zigrossi P , et al.   Parenchymal renal involvement in three cases of non-Hodgkin's lymphoma: clinical and pathological features . Haematologica . 1993;78:58–60
  20. Tsang K , Kneafsey P , Gill MJ . Primary lymphoma of the kidney in the acquired immunodeficiency syndrome . Arch Pathol Laby Med . 1993;117:541–543
  21. Okuno SH , Hoyer JD , Ristow K , et al.   Primary renal non-Hodgkin's lymphoma: an unusual extranodal site . Cancer . 1995;75:2258–2261
  22. Glicklich J , Hakenberg OW , Naumann R , et al.   Primary renal non-Hodgkin's lymphoma, a difficult diagnosis . Onkologie . 2002;25:273–277
  23. Ladha A , Haider G . Primary renal lymphoma . J Coll Physicians Surg Pak . 2008;18:584–585
  24. Tefekli A , Baykal M , Binbay M , et al.   Lymphoma of the kidney: primary or initial manifestation of rapidly progressive disease? . Int Urol Nephrol . 2006;38:775–778
  25. Porocaro AB , D'Amico A , Novella G , et al.   Primary lymphoma of the kidney: report of a case and update of the literature . Arch Ital Urol Androl . 2002;74:44–47
  26. Olusanya A , Gregory H , Olufemi A , et al.   Primary renal lymphoma presenting with acute renal failure . J Nat Med Assoc . 2003;95:220–224
  27. Richards MA , Mootoosamy I , Reznek RH , et al.   Renal involvement in patients with non-Hodgkin's lymphoma: clinical and pathological features in 23 cases . Hematol Oncol . 1990;8:105–110
  28. Chamsangavej C . Lymphoma of the genitourinary tract . Radiol Clin North Am . 1990;28:865–877
  29. Obrador GT , Price B , O'Meara Y , et al.   Acute renal failure due to lymphomatous infiltration of the kidneys . J Am Soc Nephrol . 1997;8:1348–1354
  30. Nishikawa K , Sekiyama S , Suzuki T , et al.   A case of angiotropic large cell lymphoma manifesting nephrotic syndrome and treated successfully with combination chemotherapy . Nephron . 1991;58:479–482
  31. Agar JWM , Gates PC , Vaughan SL . Renal biopsy in angiotropic large cell lymphoma . Am J Kidney Dis . 1994;24:92–96
  32. Poderly W , Cantwell B , Penelly J , et al.   Renal glomerulopathies associated with Hodgkin's disease . Cancer . 1985;56:874–875
  33. Dabbs DJ , Morel-Maroger L , Mignon F , et al.   Glomerular lesions in lymphoma and leukemias . Am J Med . 1986;80:63–70
  34. Moulin B , Ronco PM , Mougenot B , et al.   Glomerulonephritis in chronic lymphocytic leukemia and related-B-cell lymphomas . Kidney Int . 1992;42:127–135
  35. Rosas SE , Tomaszewski JE , Feldman HI , et al.   Membranoproliferative glomerulonephritis type I, mixed cryoglobulinemia and lymphoma in the absence of hepatitis C infection . Am J Nephrol . 1999;19:599–604
  36. Strokes MB , Wood B , Alpers CE . Membranoproliferative glomerulonephritis associated with low-grade B-cell lymphoma presenting in the kidney . Clin Nephrol . 2002;57:303–309
  37. Tornroth T , Heiro M , Marcussen N , Franssila K . Lymphomas diagnosed by percutaneous kidney biopsy . Am J Kidney Dis . 2003;42:960–971
  38. Alshayeb H , Wall BM . Non Hodgkin's lymphoma associated membranoproliferative glomerulonephritis: rare case of long term remission with chemotherapy-a case report . Cases J . 2009;2:201–204
  39. Audard V , Larousserie F , Grimbert P , et al.   Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: a report of 21 cases and review of literature . Kidney Int . 2006;69:2251–2260
  40. Korzets Z , Golan E , Monor Y , et al.   Spontaneously remitting minimal change nephropathy preceding a relapse of Hodgkin's disease by 19 months . Clin Nephrol . 1992;38:125–127
  41. Lanore JJ , Brunet F , Pochard F , et al.   Hemodialysis for acute renal failure in patients with hematologic malignancies . Crit Care Med . 1991;19:346–351
  42. Vardiman JW , Pierre R , Thiele J . Chronic myelogenous leukemia . In:  ES Jaffe ,  NL Harris ,  H Stein , et al. editor. Tumors of Haematopoietic and Lymphoid Tissues . Washington, DC: IARC Press; 2001;p. 20–26
  43. Xiao JC , Walz-Mattmuller R , Ruck P , et al.   Renal involvement in myeloproliferative and lymphoproliferative disorders: a study of autopsy cases . Gen Diagn Pathol . 1997;142:147–153
  44. Kanno Y , Sakuyama M , Niitsu H , et al.   Renal and electrolyte disturbances in chronic myelogenous leukemia . Rinsho Ketsueki . 1992;33:1128–1135
  45. Talwar R , Dash SC , Kucheria K , et al.   A case of chronic myeloid leukemia complicated with minimal change nephrotic syndrome . Acta Haematol . 2003;109:101–103
  46. Springate JE , Brecher M , Brentjens J , et al.   Glomerulonephritis and chronic myelogenous leukemia . Child Nephrol Urol . 1988;89:298–300
  47. Morschhauser F , Wattel E , Pagniez D , et al.   Glomerular injury in chronic myelo-monocytic leukemia . Leuk Lymphoma . 1995;18:479–483
  48. Lieutaud T , Mejean A , Prayssac P , et al.   Renal and adrenal gland localization of chronic myelo-monocytic leukemia presenting as a kidney tumor . Leuk Lymphoma . 1999;34:405–408
  49. Bane AL , Enright H , Sweeney EC . Chronic myelo-monocytic leukemia revealed by uncontrollable hematuria . Arch Pathol Lab Med . 2001;125:657–659
  50. Robinson GT , Sundaram KR , Dilly SA , et al.   Renal failure in a patient with chronic myelo-monocytic leukemia . Nephrol Dial Transplant . 1997;12:1500–1502
  51. Philips JK , Bass PS , Majumdar G , et al.   Renal failure caused by leukemic infiltration in chronic lymphocytic leukemia . J Clin Pathol . 1993;46:1131–1133
  52. Kirshbaum JD , Preuss FS . Leukemia: a clinical and pathological study of one hundred and twenty-three fatal cases in a series of 14,400 necropsies . Arch Intern Med . 1993;71:777–792
  53. Schwartz JB , Samsuddin AM . The effects of leukemic infiltrates in various organs in chronic lymphocytic leukemia . Hum Pathol . 1981;12:432–440
  54. Barcos M , Lane W , Gomez GA , et al.   An autopsy study of 1206 acute and chronic leukemia . Cancer . 1987;60:827–837
  55. Saggi S , Calandri C , Muhlfeldr T , et al.   Renal failure due to leukemic infiltration in chronic lymphocytic leukemia: case report . Nephrol Dial Transplant . 1990;5:1051–1052
  56. Tucker B , Brown AL , D'Ardenne AJ , et al.   Reversible renal failure due to renal infiltration and associated tubulointerstitial disease in chronic lymphocytic leukemia . Nephrol Dial Transplant . 1990;5:616–618
  57. Moulin B , Ronco PM , Mougenot B , et al.   Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas . Kidney Int . 1992;42:127–135
  58. Eisterer W , Neyer U , Hilbe W , et al.   Effect of cyclosporine A in a patient with refractory nephrotic syndrome associated with B chronic lymphocytic leukemia . Nephron . 1996;72:468–471
  59. Butty H , Asfoura J , Cortese F , et al.   Chronic lymphocytic leukemia-associated membranous glomerulopathy: remission with fludarabine . Am J Kidney Dis . 1999;33:E8
  60. N Da'as , A Polliac , Y Cohen , et al.   Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients . Eur J Haematol . 2001;67:158–164
  61. Touchard G , Perud'Homme JL , Aucouturier P , et al.   Nephrotic syndrome associated with chronic lymphocytic leukemia: an immunological and pathological study . Clin Nephrol . 1989;31:107–116
  62. Blade J , Kyle RA , Greipp PR . Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years . Br J Haematol . 1996;93:345–351
  63. V Eleutherakis-Papaiakovou , A Bamis , D Gika , et al.   Renal failure in multiple myeloma: incidence, correlation and diagnostic significance . Leuk Lymphoma . 2007;48:337–341
  64. Goldschmidt H , Lannert H , Bommer J , et al.   Multiple myeloma and renal failure . Nephrol Dial Transplant . 2000;15:301–305
  65. Blade J , Fernandez-LIama P , Bosch F , et al.   Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution . Arch Intern Med . 1998;158:1889–1894
  66. Buxbaum JN , Chuba JV , Hellman GC , et al.   Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis: clinical features, immunopathology and molecular analysis . Ann Intern Med . 1990;112:455–460
  67. Sanders PW . Dysproteinemias and amyloidosis . In:  A Greenberg editors. Primer on Kidney Diseases . 2nd edition. London: Academic Press; 1998;p. 220–221
  68. Appel GB , Radhakrishnan J , V D'Agati . Secondary glomerular disease: light chain deposition disease . In:  BM Brenner editors. Brenner and Rectors: The Kidney . 8th ed. Philadelphia: Saunders Elsevier; 2004;p. 1106–1107
  69. Pozzi C , D'Amico M , Fogazzi GB , et al.   Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors . Am J Kidney Dis . 2003;42:1154–1163
  70. Leung N , Lager DJ , Gertz MA , et al.   Long-term outcome of renal transplantation in light-chain deposition disease . Am J Kidney Dis . 2004;43:147–153
  71. Chauveau D , Chaukroun G . Bence Jones proteinuria and myeloma kidney . Nephrol Dial Transplant . 1996;11:413–415
  72. Sanders PW , Booker BB . Pathobiology of cast nephropathy from human Bence Jones proteins . J Clin Invest . 1992;89:630–635
  73. Goldschmidt H , Lannert H , Boomer J , et al.   Renal failure in multiple myeloma “the myeloma kidney”: state of the art . Saudi J Kidney Dis Transplant . 2001;12:145–150
  74. Winearls GG . Acute myeloma kidney . Kidney Int . 1995;48:1347–1351
  75. Lameire N , Van-Biesen W , Vanholder R , et al.   Acute renal failure . Lancet . 2005;365:417–430
  76. Batuman V . Proximal tubular injury in myeloma . Contrib Nephrol . 2007;153:87–104
  77. Decourt C , Rocca A , Bridoux F , et al.   Multinational analysis in murine models for myeloma-associated Fanconi's syndrome or cast nephropathy . Blood . 1999;94:3559–3566
  78. Somlens P , Barnes JL , Kreisberg R . Hypercalcemia can potentiate the nephrotoxicity of Bence Jones proteins . J Lab Clin Med . 1987;110:460–463
  79. CS McCarthy , JA Becker . Multiple myeloma and contrast media . Radiology . 1992;183:519–525
  80. Tepel M , Giet MVD , Schwarzfeld C , et al.   Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine . N Engl J Med . 2000;343:180–184
  81. Kyle RA , Certz MA , Witzig TE , et al.   Review of 1027 patients with newly diagnosed multiple myeloma . Mayo Clin Proc . 2003;78:21–33
  82. Kyle RA , Remstein ED , Therneau TM , et al.   Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma . N Engl J Med . 2007;356:2582–2590
  83. He Y , Wheatley K , Clark O , et al.   Early versus deferred treatment for early stage multiple myeloma . Cochrane Database Syst Rev . 2003;CD004023
  84. Dimopoulos MA , Moulopoulos A , Smith T , et al.   Risk of disease progression in asymptomatic multiple myeloma . Am J Med . 1993;94:57–61
  85. Kyle RA , Rajkumar SV . Multiple myeloma . Blood . 2008;111:2962–2972
  86. Kyle RA , Rajkumar SV . Multiple myeloma . N Engl J Med . 2004;351:1860–1873
  87. San Miguel JF . Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma . N Engl J Med . 2008;359:906–917
  88. Durie BGM . Treatment of myeloma: are we making progress? . N Engl J Med . 2008;359:964–966
  89. Zonder JA , Crowley J , Hussein MA , et al.   Superiority of lenalidomide (Len) plus high-dose dexamethasone (HD) compared to HD alone as treatment of newly-diagnosed multiple myeloma (NDMM): results of randomized, double-blinded, placebo-controlled SWOG trial . Blood . 2007;110:32a; [abstract 77].
  90. Rajkumar SV , Jacobus S , Callander N , et al.   Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomized controlled trial . Lancet Oncol . 2010;11:29–37
  91. Facon T , Mary JY , Hulin C , et al.   Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced intensity autologous stem cell transplantation in elderly patients with multiple myeloma: a randomized trial . Lancet . 2007;370:1209–1218
  92. Palumbo A , Falco P , Falcone A , et al.   Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results . Clin Lymphoma Myeloma . 2009;9:145–150
  93. Hulin C , Facon T , Rodon P , et al.   Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma . J Clin Oncol . 2009;27:3664–3670
  94. Mateos MV , Hernandez JM , Hernandez MT , et al.   Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of multicenter phase I/II study . Blood . 2006;108:2165–2172
  95. Berenson JR , Lichtenstein A , Porter L , et al.   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma: Myeloma Aredia Study Group . N Engl J Med . 1996;334:488–493
  96. Kyle RA , Yee GC , Somerfield MR , et al.   American Society of Clinical Oncology 2007: clinical practice guideline update on the role of bisphosphonates in multiple myeloma . J Clin Oncol . 2007;25:2464–2472
  97. Wang EP , Kaban LB , Strewler GJ , et al.   Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphospphonate therapy . J Oral Maxillofac Surg . 2007;65:1328–1331
  98. American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma: National Guideline Clearinghouse . Available at http://www.guideline.gov/summary.aspx?docid=10857&nbr=005670 Accessed May 1, 2009.
  99. Benguin Y . Erythropoiesis and erythropoietin in multiple myeloma . Leuk Lymphoma . 1995;18:413–421
  100. Mikhael J , Melosky B , Cripps C , et al.   Canadian supportive care recommendations for the management of anemia in patients with cancer . Curr Oncol . 2007;14:209–217
  101. Baz R , Walker E , Cohoueiri TK , et al.   Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma . Acta Haematol . 2007;117:162–167
  102. Ludwig H , Drach J , Graf H , et al.   Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma . Haematologica . 2007;92:1411–1414
  103. Vickrey E , Allen S , Mehta J , et al.   Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy . Cancer . 2009;115:229–232
  104. IS Abdul-Rahman . A prospective study of renal failure in multiple myeloma: a promising role for plasmapheresis . Haema . 2003;6:358–365
  105. Johnson WJ , Kyle RA , Pineda AA , et al.   Treatment of renal failure associated with multiple myeloma . Arch Intern Med . 1990;150:863–869
  106. Clark WF , Stewart AK , Rock GA , et al.   Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial . Ann Intern Med . 2005;143:777–784
  107. Ritz E . Plasma exchange for acute renal failure of multiple myeloma: logical yet ineffective . J Am Soc Nephrol . 2006;17:914–916
  108. Cserti C , Haspel R , Stowell C , et al.   Light-chain removal by plasmapheresis in myeloma-associated renal failure . Transfusion . 2007;47:511–514
  109. Evans N , Hattersley J , Hutchinson C , et al.   Modelling of hemodialysis in limiting serum free light-chains in patients with renal failure . In:  DD Feng ,  J Zaytoon editor. Proceedings of the 6th IFAC Symposium on Modelling and Control in Biomedical Systems . Oxford: Elsevier; 2006;p. 75–80
  110. Leung N , Gertz MA , Zeldenrust SR , et al.   Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains . Kidney Int . 2008;73:1282–1288
  111. Hutchison CA , Bradwell AR , Cook M , et al.   Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis . Clin J Am Soc Nephrol . 2009;4:745–754
  112. Basnayake K , Hutchison C , Kamel D , et al.   Resolution of cast nephropathy following free light chain removal by hemodialysis in a patient with multiple myeloma: a case report . J Med Case Rep . 2008;2:380–385
  113. Davidson MB , Thakkar S , Hix JK , et al.   Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome . Am J Med . 2004;116:546–554
  114. Jones DP , Mahmoud H , Chesney RW . Tumor lysis syndrome: pathogenesis and management . Pediatr Nephrol . 1995;9:206–212
  115. Flombaum CD . Metabolic emergencies in the cancer patients . Semin Oncol . 2000;27:322–334
  116. Fassas AB , Desikan KR , Siegel D , et al.   Tumor lysis syndrome complicating high-dose treatment in patients with multiple myeloma . Br J Haematol . 1999;105:938–941
  117. Backsgaard I , Sorenson JB . Acute tumor lysis syndrome in solid tumors: a case report and review of the literature . Cancer Chemother Pharmacol . 2003;51:187–192
  118. Richardson P , Hideshima T , Anderson KC . Multiple myeloma and related disorders . In:  MD Abeloff ,  JO Armitag ,  JE Niederhuber , et al. editor. Clinical Oncology . 3rd edition. Philadelphia: Elsevier Churchill Livingstone; 2004;p. 2970–2971
  119. Terpos E , Politou M , Rahemtulla A . Tumor lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration . J Cancer Res Clin Oncol . 2004;130:623–625
  120. Bickert B , Reilly A . Pediatric tumor lysis syndrome . J Pharm Pract . 2004;17:447–454
  121. Arrambide K , Toto RD . Tumor lysis syndrome . Semin Nephrol . 1993;13:273–280
  122. Coiffier B , Altman A , Pui CH , et al.   Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review . J Clin Oncol . 2008;26:2767–2778
  123. Sallan S . Management of acute tumor lysis syndrome . Semin Oncol . 2001;28(Suppl 5):9–12
  124. Rampello E , Fricia T , Malaguarnera M . The management of tumor lysis syndrome . Nat Clin Pract Oncol . 2006;8:438–447
  125. Balint E , Marshall CF , Sprague SM . Effects of the vitamin D analogues paricalcitol and calcitonin . Am J Kidney Dis . 2000;36:789–796
  126. Singer GG , Brenner BM . Fluid and electrolyte disturbances . In:  E Braunwald ,  AS Fauci ,  DL Kasper , et al. editor. Harrison's Principles of Internal Medicine . 15th edition. New York: McGraw-Hill; 2001;p. 271–283
  127. Pui CH , Relling MV , Lascombes F , et al.   Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies . Leukemia . 1997;11:1813–1816
  128. Ueng S . Rasburicase (Elitek): a novel agent for tumor lysis syndrome . BUMC Proc . 2005;18:275–279
  129. Coiffier B , Mounier N , Bologna S , et al.   Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Group d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study . J Clin Oncol . 2003;21:4402–4406
  130. Cairo MS , Bishop M . Tumor lysis syndrome: new therapeutic strategies and classification . Br J Haematol . 2004;127:3–11
  131. Pui CH , Mahmoud HH , Wiley JM , et al.   Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma . J Clin Oncol . 2001;19:697–704
  132. Goldman SC , Holcenberg JS , Finklestein JZ , et al.   A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis . Blood . 2001;97:2998–3003
  133. Kersting S , Koomans HA , Hene RJ , et al.   Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival . Bone Marrow Transplant . 2007;39:359–365
  134. Hingorani SR , Guthrie K , Batchelder A , et al.   Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors . Kidney Int . 2005;67:272–277
  135. Moak JL , Byrnes JJ . Thrombotic microangiopathies associated with drugs and bone marrow transplantation . Hematol Oncol Clin North Am . 1996;10:485–497
  136. George JN , Li X , McMinn JR , et al.   Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma . Transfusion . 2004;44:294–304
  137. Miralbell R , Dieri S , Mermillod B , et al.   Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease . J Clin Oncol . 1996;14:579–585
  138. Cohen EP , Lawton CA , Moulder JE , et al.   Clinical course of late-onset bone marrow transplant nephropathy . Nephron . 1993;64:626–634
  139. Cohen EP , Lawton CA , Moulder JE , et al.   Bone marrow transplant nephropathy: radiation nephritis revisited . Nephron . 1995;70:217–222
  140. Zenz T , Schlenk RF , Glatting G , et al.   Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation . J Nucl Med . 2006;47:278–286
  141. Van Why SK , AL Friedman , LJ Wei , et al.   Renal insufficiency after bone marrow transplantation in children . Bone Marrow Transplant . 1991;7:383–388
  142. Parikh CR , McSweeney PA , Korulas D , et al.   Renal dysfunction in allogeneic hematopoietic cell transplantation . Kidney Int . 2002;62:566–573
  143. Cruz DN , Perazella MA , Mahnensmith RL . Bone marrow transplant nephropathy: a case report and review of literature . J Am Soc Nephrol . 1997;8:166–173
  144. Ishizuka Y , Yokota A , Hara S , et al.   Transient nephrotic syndrome after allogeneic bone marrow transplantation for chronic myelogenous leukemia . Jpn J Clin Hematol . 2001;42:321–327
  145. Rossi L , Gardarelli F , Vampa ML , et al.   Membranous glomerulo-nephritis after hematopoietic cell transplantation for multiple myeloma . Nephron . 2001;88:260–263
  146. Chien YH , Lin KH , Lee TY , et al.   Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease . J Formos Med Assoc . 2000;99:503–506
  147. Ohsawa I , Ohi H , Fujita T , et al.   Glomerular and extraglomerular immune complex deposits in a bone marrow transplant recipient . Am J Kidney Dis . 2000;36:E3
  148. Kimura S , Horei A , Hiki Y , et al.   Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma . Blood . 2003;101:4219–4221
  149. Silva VA , Frei-lahr D , Brown RA , et al.   Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation . J Clin Apheresis . 1991;6:16–20
  150. Li C , Lim SW , Sun BK , et al.   Chronic cyclosporine nephrotoxicity: new insights and preventive strategies . Yonsei Med J . 2004;45:1004–1016
  151. Lawton CA , Cohen EP , Murray KJ , et al.   Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation . Bone Marrow Transplant . 1997;20:1069–1074
  152. Tarbell NJ , Guinan EC , Chin L , et al.   Renal insufficiency after total body irradiation for pediatric bone marrow transplantation . Radiother Oncol . 1990;18(Suppl 1):139–142
  153. Cohen EP . Radiation nephropathy after bone marrow transplantation . Kidney Int . 2000;58:903–918
  154. Lawton C , Fish BL , Moulder JE . Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantation . Int J Radiat Oncol Biol Phys . 1994;28:883–889
  155. Sayegh MH , Milford EL , Fine NA , et al.   Immunologic tolerance to renal allografts after bone marrow transplants from the same donors . Ann Intern Med . 1991;114:954–955
  156. Scandling JD , Busque S , Dejbakhsh-Jones S , et al.   Tolerance and chimerism after renal and hematopoietic-cell transplantation . N Engl J Med . 2008;358:362–368

PII: S1561-5413(11)60002-1

doi:10.1016/S1561-5413(11)60002-1

Hong Kong Journal of Nephrology
Volume 13, Issue 1 , Pages 5-18, April 2011

Article Tools